Shiv Krishnan, PhDSenior Director and Head, Business Development & Licensing-Innovative Technologies at Sanofi
Shiv Krishnan leads Business Development & Licensing for Innovative Technologies in Sanofi. In this capacity, he leads a global search-evaluation-licensing effort focused on technologies that deals with the entire value chain (Research, Development, Manufacturing) of Biologics, Gene Therapy, Drug Discovery and Translational Technologies. He also works closely with innovators in academia and biotech companies to identify exciting breakthroughs that could fill Sanofi’s technology gaps. After graduating with a PhD in biochemistry from the University of Technology, Compiegne, France, Shiv spent the early part of his career in France working as a scientist in biotech at Transgene S.A, and then in the field of vaccines at Sanofi Pasteur. He went on to work at Gencell, the gene therapy division of Rhone Poulenc Rorer-until the creation of Aventis at which point he transferred to the United States. Shiv has been active in developing alliances with academia and biotech for the past 18 years covering the entire partnering value chain. He has a keen interest in breakthrough, translational innovation and the business models that support this. Shiv is active in the innovation ecosystem development and participation at conferences and partnering events.